Literature DB >> 20876373

Independent behavior of commensal flora for carriage of fluoroquinolone-resistant bacteria in patients at admission.

Victoire de Lastours1, Françoise Chau, Florence Tubach, Blandine Pasquet, Etienne Ruppé, Bruno Fantin.   

Abstract

The important role of commensal flora as a natural reservoir of bacterial resistance is now well established. However, whether the behavior of each commensal flora is similar to that of other floras in terms of rates of carriage and risk factors for bacterial resistance is unknown. During a 6-month period, we prospectively investigated colonization with fluoroquinolone-resistant bacteria in the three main commensal floras from hospitalized patients at admission, targeting Escherichia coli in the fecal flora, coagulase-negative Staphylococcus (CNS) in the nasal flora, and α-hemolytic streptococci in the pharyngeal flora. Resistant strains were detected on quinolone-containing selective agar. Clinical and epidemiological data were collected. A total of 555 patients were included. Carriage rates of resistance were 8.0% in E. coli, 30.3% in CNS for ciprofloxacin, and 27.2% in streptococci for levofloxacin; 56% of the patients carried resistance in at least one flora but only 0.9% simultaneously in all floras, which is no more than random. Risk factors associated with the carriage of fluoroquinolone-resistant strains differed between fecal E. coli (i.e., colonization by multidrug-resistant bacteria) and nasal CNS (i.e., age, coming from a health care facility, and previous antibiotic treatment with a fluoroquinolone) while no risk factors were identified for pharyngeal streptococci. Despite high rates of colonization with fluoroquinolone-resistant bacteria, each commensal flora behaved independently since simultaneous carriage of resistance in the three distinct floras was uncommon, and risk factors differed. Consequences of environmental selective pressures vary in each commensal flora according to its local specificities (clinical trial NCT00520715 [http://clinicaltrials.gov/ct2/show/NCT00520715]).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20876373      PMCID: PMC2981286          DOI: 10.1128/AAC.00823-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  42 in total

1.  Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant gram-negative bacilli from gastrointestinal flora.

Authors:  P Richard; M H Delangle; F Raffi; E Espaze; H Richet
Journal:  Clin Infect Dis       Date:  2000-12-11       Impact factor: 9.079

2.  Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.

Authors:  Ross Davidson; Rodrigo Cavalcanti; James L Brunton; Darrin J Bast; Joyce C S de Azavedo; Pamela Kibsey; Christine Fleming; Donald E Low
Journal:  N Engl J Med       Date:  2002-03-07       Impact factor: 91.245

3.  Recruitment of the mecA gene homologue of Staphylococcus sciuri into a resistance determinant and expression of the resistant phenotype in Staphylococcus aureus.

Authors:  S W Wu; H de Lencastre; A Tomasz
Journal:  J Bacteriol       Date:  2001-04       Impact factor: 3.490

4.  Evidence for extensive resistance gene transfer among Bacteroides spp. and among Bacteroides and other genera in the human colon.

Authors:  N B Shoemaker; H Vlamakis; K Hayes; A A Salyers
Journal:  Appl Environ Microbiol       Date:  2001-02       Impact factor: 4.792

Review 5.  Mechanisms of action of antimicrobials: focus on fluoroquinolones.

Authors:  D C Hooper
Journal:  Clin Infect Dis       Date:  2001-03-15       Impact factor: 9.079

6.  Emergence and dissemination of quinolone-resistant Escherichia coli in the community.

Authors:  J Garau; M Xercavins; M Rodríguez-Carballeira; J R Gómez-Vera; I Coll; D Vidal; T Llovet; A Ruíz-Bremón
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

7.  Fluoroquinolone resistance associated with target mutations and active efflux in oropharyngeal colonizing isolates of viridans group streptococci.

Authors:  F Guerin; E Varon; A B Hoï; L Gutmann; I Podglajen
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

8.  Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure.

Authors:  R A Venezia; B E Domaracki; A M Evans; K E Preston; E M Graffunder
Journal:  J Antimicrob Chemother       Date:  2001-09       Impact factor: 5.790

Review 9.  Effect of antimicrobial agents on the ecological balance of human microflora.

Authors:  A Sullivan; C Edlund; C E Nord
Journal:  Lancet Infect Dis       Date:  2001-09       Impact factor: 25.071

10.  Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999.

Authors:  David M Livermore; Dorothy James; Mark Reacher; Catriona Graham; Thomas Nichols; Peter Stephens; Alan P Johnson; Robert C George
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

View more
  10 in total

1.  Impact of antibiotic use during hospitalization on the development of gastrointestinal colonization with Escherichia coli with reduced fluoroquinolone susceptibility.

Authors:  Jennifer H Han; Warren B Bilker; Irving Nachamkin; Pam Tolomeo; Xiangqun Mao; Neil O Fishman; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2013-08-23       Impact factor: 3.254

2.  Traumatic wound microbiome workshop.

Authors:  B C Kirkup; D W Craft; T Palys; C Black; R Heitkamp; C Li; Y Lu; N Matlock; C McQueary; A Michels; G Peck; Y Si; A M Summers; M Thompson; D V Zurawski
Journal:  Microb Ecol       Date:  2012-05-24       Impact factor: 4.552

3.  Prospective Cohort Study of the Relative Abundance of Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli in the Gut of Patients Admitted to Hospitals.

Authors:  Victoire de Lastours; Dorothée Chopin; Hervé Jacquier; Camille d'Humières; Charles Burdet; Françoise Chau; Erick Denamur; Bruno Fantin
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

Review 4.  Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Authors:  A Dalhoff
Journal:  Infection       Date:  2012-03-30       Impact factor: 3.553

5.  Determinants of antimicrobial resistance in Escherichia coli strains isolated from faeces and urine of women with recurrent urinary tract infections.

Authors:  Casper D J den Heijer; Mariëlle A J Beerepoot; Jan M Prins; Suzanne E Geerlings; Ellen E Stobberingh
Journal:  PLoS One       Date:  2012-11-16       Impact factor: 3.240

6.  Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community.

Authors:  Evelien M E van Bijnen; W John Paget; Casper D J den Heijer; Ellen E Stobberingh; Cathrien A Bruggeman; François G Schellevis
Journal:  BMC Fam Pract       Date:  2014-10-25       Impact factor: 2.497

7.  Extended-spectrum β-lactamase, plasmid-mediated AmpC β-lactamase, fluoroquinolone resistance, and decreased susceptibility to carbapenems in Enterobacteriaceae: fecal carriage rates and associated risk factors in the community of Northern Cyprus.

Authors:  Emrah Ruh; Jonathan Zakka; Kujtesa Hoti; Arezou Fekrat; Emrah Guler; Umut Gazi; Zafer Erdogmus; Kaya Suer
Journal:  Antimicrob Resist Infect Control       Date:  2019-06-10       Impact factor: 4.887

8.  An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones.

Authors:  Maria J G T Vehreschild; Annie Ducher; Thomas Louie; Oliver A Cornely; Celine Feger; Aaron Dane; Marina Varastet; Fabien Vitry; Jean de Gunzburg; Antoine Andremont; France Mentré; Mark H Wilcox
Journal:  J Antimicrob Chemother       Date:  2022-03-31       Impact factor: 5.790

9.  Antibiotic Exposure and Other Risk Factors for Antimicrobial Resistance in Nasal Commensal Staphylococcus aureus: An Ecological Study in 8 European Countries.

Authors:  Evelien M E van Bijnen; John Paget; Elly S M de Lange-de Klerk; Casper D J den Heijer; Ann Versporten; Ellen E Stobberingh; Herman Goossens; François G Schellevis
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

10.  The effect of preheated versus room-temperature skin disinfection on bacterial colonization during pacemaker device implantation: a randomized controlled non-inferiority trial.

Authors:  Camilla Wistrand; Bo Söderquist; Anders Magnusson; Ulrica Nilsson
Journal:  Antimicrob Resist Infect Control       Date:  2015-11-03       Impact factor: 4.887

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.